These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26332793)

  • 21. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
    Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing second echelon lymph nodes during sentinel lymph node biopsy: can we have more accurate axillary treatment for breast cancer patients?
    Chen K; Jia W; Rao N; Deng H; Jin L; Song E; Su F
    Med Hypotheses; 2011 Dec; 77(6):987-9. PubMed ID: 21908107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolving role of axillary lymph node dissection in the modern era of breast cancer management.
    Barry JM; Weber WP; Sacchini V
    Surg Oncol; 2012 Jun; 21(2):143-5. PubMed ID: 21440434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized clinical trial on sentinel lymph node dissection versus axillary dissection: a matter of technique.
    Kruper L; Giuliano AE
    Ann Surg; 2008 Feb; 247(2):214-6. PubMed ID: 18216524
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
    Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
    Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Positive sentinel node in breast cancer - when and why also opt for axillary dissection?].
    Krsička P; Coufal O; Zapletal O
    Rozhl Chir; 2013 Dec; 92(12):684-9. PubMed ID: 24479511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel node biopsy in breast cancer has a greater node positivity rate than axillary node sample: results from a retrospective analysis.
    Macaskill EJ; Dewar S; Purdie CA; Brauer K; Baker L; Brown DC
    Eur J Surg Oncol; 2012 Aug; 38(8):662-9. PubMed ID: 22592099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.
    Shah-Khan M; Boughey JC
    Cancer Control; 2012 Oct; 19(4):267-76. PubMed ID: 23037494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel Lymph Node Biopsy in Breast Cancer Surgery.
    Dixon JM
    Ann Surg Oncol; 2016 Oct; 23(11):3426-3428. PubMed ID: 27448117
    [No Abstract]   [Full Text] [Related]  

  • 30. Axillary sentinel lymph node biopsy: an overview.
    Rovera F; Frattini F; Marelli M; Corben AD; Dionigi G; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S109-12. PubMed ID: 19131285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
    Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
    Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Axillary Lymph Node Dissection Necessary After a Positive Sentinel Lymph Node Biopsy?
    Ozcan LC; Giuliano AE
    Adv Surg; 2017 Sep; 51(1):165-178. PubMed ID: 28797338
    [No Abstract]   [Full Text] [Related]  

  • 33. Sentinel lymph nodes for breast carcinoma: an update on current practice.
    Maguire A; Brogi E
    Histopathology; 2016 Jan; 68(1):152-67. PubMed ID: 26768036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of sentinel node biopsy - response.
    Mann GB
    Surgeon; 2015 Feb; 13(1):60. PubMed ID: 25087503
    [No Abstract]   [Full Text] [Related]  

  • 35. Measuring the impact of the American College of Surgeons Oncology Group Z0011 trial on breast cancer surgery in a community health system.
    Wright GP; Mater ME; Sobel HL; Knoll GM; Oostendorp LD; Melnik MK; Chung MH
    Am J Surg; 2015 Feb; 209(2):240-5. PubMed ID: 25236187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting.
    Ngui NK; Elder EE; Jayasinghe UW; French J
    ANZ J Surg; 2013 Dec; 83(12):924-8. PubMed ID: 24289051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contraindications for a sentinel node biopsy in breast cancer are actually indications.
    Tjalma WA
    Surgeon; 2015 Feb; 13(1):59. PubMed ID: 25087504
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are Lymph Node Characteristics on Axillary Ultrasound Associated with ≥3 Positive Lymph Nodes in Patients Managed by the American College of Surgeons Oncology Group Z0011 Trial Criteria?
    Rooney EG; Fleming MM; Patel JG; Clifford K; Kim C; Chen Z; Gillespie TW; Arciero CA; Subhedar PD
    Am Surg; 2018 Jul; 84(7):1133-1137. PubMed ID: 30064576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Krynyckyi BR; Shim J; Lim I
    Cancer; 2004 Feb; 100(3):654-5; author reply 655-6. PubMed ID: 14745886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.